4.1 Editorial Material

CMV-related anterior and intermediate uveitis in a kidney transplant recipient treated with belatacept

Related references

Note: Only part of the references are listed.
Article Surgery

Increased incidence and unusual presentations of CMV disease in kidney transplant recipients after conversion to belatacept

Nathalie Chavarot et al.

Summary: This study analyzed the characteristics and risk factors of CMV disease after conversion to Belatacept in kidney transplant recipients, finding that older age, D+/R- CMV serostatus, and low eGFR at conversion were independent risk factors. The incidence and cumulative incidence of CMV disease were significantly higher in patients treated with Belatacept compared to the control group.

AMERICAN JOURNAL OF TRANSPLANTATION (2021)

Article

CYTOMEGALOVIRUS RETINITIS WITH BELATACEPT IMMUNOSUPPRESSION

Jason Fan et al.

Retinal Cases and Brief Reports (2019)

Review Ophthalmology

Clinical Features of CMV-Associated Anterior Uveitis

Nicole Shu-Wen Chan et al.

OCULAR IMMUNOLOGY AND INFLAMMATION (2018)

Article Ophthalmology

Diagnosis of Cytomegalovirus Anterior Uveitis in Two European Referral Centers

Lia Judice M. Relvas et al.

OCULAR IMMUNOLOGY AND INFLAMMATION (2018)

Article Ophthalmology

Cytomegalovirus Anterior Uveitis: Clinical Characteristics and Long-term Outcomes in a French Series

Sara Touhami et al.

AMERICAN JOURNAL OF OPHTHALMOLOGY (2018)

Article Ophthalmology

Cytomegalovirus anterior uveitis: outcome of treatment

S-P Chee et al.

BRITISH JOURNAL OF OPHTHALMOLOGY (2010)

Article Ophthalmology

Clinical features of cytomegalovirus anterior uveitis in immunocompetent patients

Soon-Phaik Chee et al.

AMERICAN JOURNAL OF OPHTHALMOLOGY (2008)